A股異動 | 江蘇吳中漲停 擬收購上海維娜 加快推進醫美產業佈局
格隆匯9月29日丨江蘇吳中(600200.SH)開盤漲停,報8元,總市值57億元。江蘇吳中28日發佈公吿,公司與維娜香港有限公司、上海維娜化粧品有限公司簽署股權收購意向協議。維娜香港現持有上海維娜100%股權,公司或公司全資子公司擬收購上海維娜不少於70%的股權,雙方暫定上海維娜100%股權的收購對價約7億元。此次擬收購上海維娜股權有利於加快推進公司醫美產業戰略落地和規模化運營佈局,拓展公司醫美板塊產品管線。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.